Concepedia

Mark Przybylowski

MP

Statistics

Publications

4

Citations

1.7K

H-Index

4

Active since

2005

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Mark Przybylowski is an author at Memorial Sloan Kettering Cancer Center specializing in life sciences, phase i clinical trials, and biotechnology.

Publications per year

2005–2011

4

Publications

4

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Renier J. Brentjens, Isabelle Rivière, Jae H. Park et al. · Blood · 2011 · 1.3K citations · Full text

, , +11

Manufacturing Validation of Biologically Functional T Cells Targeted to CD19 Antigen for Autologous Adoptive Cell Therapy

Daniel Hollyman, Jolanta Stefanski, Mark Przybylowski et al. · Journal of Immunotherapy · 2009 · 319 citations · Full text

, , +17

Production of clinical-grade plasmid DNA for human Phase I clinical trials and large animal clinical studies

Mark Przybylowski, Shirley Bartido, Oriana Bórquez-Ojeda et al. · Vaccine · 2007 · 43 citations

, , +15

Production scale-up and validation of packaging cell clearance of clinical-grade retroviral vector stocks produced in Cell Factories

Mark Przybylowski, A Hakakha, J. Stefanski et al. · Gene Therapy · 2005 · 34 citations

, , +17

1–4 of 4